Home > News > IATIA score US nanotechnology contract
June 22nd, 2004
IATIA score US nanotechnology contract
Abstract:
The directors of IATIA Limited (IAT) today advised shareholders that the group has entered the field of nano-biotechnology with a US$20,000 research contract from the US based Xradia Inc. The Californian group is planning to use IATIA’s QPI phase retrieval technique to image the bone structure and soft tissues of the mice, which are used various medical experiments including the study of cancer tumour growth and treatment.
Source:
egoli
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||